Cargando…

Natural chalcones as dual inhibitors of HDACs and NF-κB

Histone deacetylase enzymes (HDACs) are emerging as a promising biological target for cancer and inflammation. Using a fluorescence assay, we tested the in vitro HDAC inhibitory activity of twenty-one natural chalcones, a widespread group of natural products with well-known anti-inflammatory and ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	ORLIKOVA, B., SCHNEKENBURGER, M., ZLOH, M., GOLAIS, F., DIEDERICH, M., TASDEMIR, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583578/ https://www.ncbi.nlm.nih.gov/pubmed/22710558 http://dx.doi.org/10.3892/or.2012.1870

Ejemplares similares

Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential
por: Harms, Henrik, et al.
Publicado: (2015)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
por: Losson, Hélène, et al.
Publicado: (2020)

Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
por: Losson, Hélène, et al.
Publicado: (2016)

The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway
por: Smith, Emma M., et al.
Publicado: (2013)

B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB
por: Cheng, Meng-Hsuan, et al.
Publicado: (2017)

HDAC-mediated Deacetylation of NF-κB is Critical for Schwann cell Myelination
por: Chen, Ying, et al.
Publicado: (2011)

Sumoylation of HDAC2 promotes NF-κB-dependent gene expression
por: Wagner, Tobias, et al.
Publicado: (2015)

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity
por: Mourad, Ahmed A E, et al.
Publicado: (2020)

Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
por: Koyiparambath, Vishal Payyalot, et al.
Publicado: (2021)

Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors
por: El-Damasy, Ashraf K., et al.
Publicado: (2023)

USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
por: Li, Z, et al.
Publicado: (2016)

HDAC7 Activates IKK/NF-κB Signaling to Regulate Astrocyte-Mediated Inflammation
por: Ye, Jinwang, et al.
Publicado: (2022)

Prognostic value of NF-κB, CD9, and VEGF in gastrointestinal stromal tumors
por: Tasdemir, Arzu, et al.
Publicado: (2013)

EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones
por: Musa, Arafa, et al.
Publicado: (2022)

Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
por: Sasidharan, Rani, et al.
Publicado: (2021)

NF-κB Inhibitors from Eurycoma longifolia
por: Tran, Thi Van Anh, et al.
Publicado: (2014)

Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions
por: Mathew, Bijo, et al.
Publicado: (2021)

Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer
por: Roy, Rubi, et al.
Publicado: (2023)

The synthesis of novel thioderivative chalcones and their influence on NF-κB, STAT3 and NRF2 signaling pathways in colorectal cancer cells
por: Papierska, Katarzyna, et al.
Publicado: (2022)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
por: Möller, Gabriele, et al.
Publicado: (2022)

Epigenetics Offer New Horizons for Colorectal Cancer Prevention
por: Schnekenburger, Michael, et al.
Publicado: (2012)

Non-Edible Plants as an Attractive Source of Compounds with Chemopreventive Potential
por: Ji, Seungwon, et al.
Publicado: (2014)

Chalcones, semicarbazones and pyrazolines as inhibitors of cathepsins B, H and L
por: Raghav, Neera, et al.
Publicado: (2015)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

Anticancer Activity of Natural and Synthetic Chalcones
por: Constantinescu, Teodora, et al.
Publicado: (2021)

Natural Chalcones for the Management of Obesity Disease
por: Maisto, Maria, et al.
Publicado: (2023)

OMICS, a multidisciplinary friendship
por: Teiten, M-H, et al.
Publicado: (2012)

HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression
por: Barter, Matt J., et al.
Publicado: (2022)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release
por: Daniel, Kevin B., et al.
Publicado: (2015)

Dual Delayed Feedback Provides Sensitivity and Robustness to the NF-κB Signaling Module
por: Longo, Diane M., et al.
Publicado: (2013)

NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis
por: Guo, Yunwei, et al.
Publicado: (2020)

Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination
por: Yadav, Anjali, et al.
Publicado: (2021)

Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
por: Gajendran, Chandru, et al.
Publicado: (2023)

Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery
por: Lee, Jin-Young, et al.
Publicado: (2015)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Regulation of Transcription Factor NF-κB in Its Natural Habitat: The Nucleus
por: Bacher, Susanne, et al.
Publicado: (2021)

Small Molecule NF-κB Pathway Inhibitors in Clinic
por: Ramadass, Venkataramanan, et al.
Publicado: (2020)

Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
por: Rehuman, Nisha Abdul, et al.
Publicado: (2021)

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
por: Avci, Naze G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6c9cd1rjniempo5q4gnl2kdo64